Bahde, Ralf <br/><br/>
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jan 2013 
 - 320-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.26005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bosentan<br/>Cardiovascular Agents--pharmacology<br/>Dipeptidyl Peptidase 4--deficiency<br/>Endothelin Receptor Antagonists<br/>Epoprostenol--pharmacology<br/>Hepatocytes--drug effects<br/>Lisinopril--pharmacology<br/>Liver--blood supply<br/>Losartan--pharmacology<br/>Nitroglycerin--pharmacology<br/>Rats<br/>Rats, Inbred F344<br/>Sulfonamides--pharmacology